Google News • 1/31/2026
Quitting Ozempic poses risks, as highlighted by various sources. The Wall Street Journal discusses the consequences of stopping Ozempic and Wegovy, while the New York Post reports on the emergence of 'agonorexia,' linked to GLP-1 medications, which may lead to new eating disorders. Additionally, HOLA provides expert advice on avoiding Ozempic’s “rebound effect.” Concerns about the long-term effectiveness of popular weight loss drugs like Ozempic are raised by ScienceDaily.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.









